Brain Cancer

Adding the immunotherapeutic vaccine Rintega (rindopepimut) to Avastin (bevacizumab) may help boost survival in patients with a genetic subtype of glioblastoma associated with poor outcomes.

Dellann Elliott Mydland, from the Chris Elliott Fund, discusses testing brain tumor tissue before surgery.

When you're told you're sick, you're also told that you're an insta-inspiration, and your will to fight is somehow supposed to grow as your suffering does. Being sick doesn't always make sense.

Cancer patients need more than any necessary conventional cancer treatments. Solutions come from integrative cancer care for the whole person. Learn about why, how to achieve optimal health and healing, and some top-notch resources.

Aug. 27, 2000, started as an ordinary day for Dellann Elliott Mydland. She and her husband Chris Elliott and their two children, then 5 and 8 years old, had just finished up a weekend at their cabin and were preparing to relax by the grill at home.

2015 started off with a bang, with a focus on brain cancer patients and new treatment options for recurrent glioblastoma (rGBM).

We spend so much time making it look like we've got it all covered, when in reality, things are unraveling just below the surface. Maybe that's OK.

It's one thing to know you have to get a certain treatment, it's another thing entirely to wait for it to come.

James Battiste, an oncologist with Stephenson Cancer Center in Oklahoma City, Okla., says patients with glioblastoma will likely have a lot of questions about the diagnosis.

Rintega (rindopepimut) has gained a Breakthrough Therapy Designation from the FDA to treat adult patients with glioblastoma multiforme (GBM) that test positive for the EGFR variant (EGFRvIII).

Lauren Hill, a college basketball player diagnosed with a rare childhood brain tumor, brought attention to the disease and raised more than $1 million for DIPG research. Hill passed away on April 10.

When caring for someone who has undergone brain surgery, practice patience and ask for support.

NORD was founded in 1983 by parents of children with rare diseases. Over the past 30 years, it has become a powerful advocacy voice for all patients with rare diseases, including cancer.

Patients who undergo surgery for brain cancer may need to be patient during recovery.

Investigational vaccine appears to help progression-free survival and overall survival in patients with a type of glioblastoma.

Immunotherapy is coming of age not only in general oncology, but also in neuro-oncology.

Advances in immunotherapy are showing progress in treating brain cancer, especially glioblastoma.

Brain cancer researchers and advocates join resources to help tackle this rare and aggressive malignancy.

In the right cancer, radiation and chemotherapy can make a powerful duo.

Patients and families face difficult decisions when the prognosis is poor, but communication and an action plan may help.

Research into vaccine therapy for cancer is extending to many cancer types.

Patients with anaplastic oligodendroglial tumors harboring certain chromosomal deletions have a reduced risk of dying after receiving radiation and chemotherapy.

Depending on the size, location and type of brain tumor, exercise can be difficult for patients, but new research shows it may impact survival. Here are a few tips to get moving.

Newer targets found on cancer cells are providing scientists the ammunition to better treat cancer.

New drug therapies aid in the treatment of prostate cancer, glioblastoma, and renal cell carcinoma.